Exposure Adjusted Continuous Reassessment Method (EACRM) - an Adaptive Design Incorporating Time to Toxicity Event for Phase I Dose Finding Studies.

Qi X^*, Munasinghe W, Chiu Y and Holen KD

Global Pharmaceutical Research and Development, AbbVie Inc, North Chicago, IL, USA, E-mail: xin.qi@abbvie.com

^*Corresponding Author: Qi X, Global Pharmaceutical Research and Development, AbbVie Inc, North Chicago, IL, USA Email: